IMPROVEMENT IN INFLAMMATORY BIOMARKER LEVELS THROUGH WEEK 12 IN MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS PATIENTS TREATED WITH GUSELKUMAB: RESULTS FROM THE PHASE 3 QUASAR INDUCTION STUDY

Tadakazu Hisamatsu  1     Laurent Peyrin-Biroulet  2     Axel Dignass  3     Gary KH Huang  4     Matthew Germinaro     Nicole Houck     Ye Miao     Hongyan Zhang     Marjorie Costa Argollo  5     Ken Takeuchi  6     Rafal Filip  7     Jessica Allegretti  8     Brian G. Feagan  9     Bruce E. Sands  10    
1 Kyorin University, Tokyo, Japan
2 Nancy University Hospital, UniversitĂ© de Lorraine, Nancy, France
3 Agaplesion Markus Hospital, Goethe University, Frankfurt, Germany
4 Janssen Research & Development, LLC, Spring House, United States
5 Onco Star SP Oncologia Ltda, Sao Paulo, Brazil
6 Tsujinaka Hospital Kashiwanoha, Kashiwa, Japan
7 Clinical Hospital No. 2, Rzeszow, Poland
8 Brigham and Women´s Hospital, Boston, United States
9 Alimentiv Inc, London, Canada
10 Icahn School of Medicine at Mount Sinai, New York, United States

Topic
IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing